Vytrus Biotech, S.A.

DB:V5P 주식 보고서

시가총액: €16.7m

Vytrus Biotech 대차 대조표 상태

재무 상태 기준 확인 6/6

Vytrus Biotech has a total shareholder equity of €6.8M and total debt of €2.0M, which brings its debt-to-equity ratio to 29.8%. Its total assets and total liabilities are €10.6M and €3.8M respectively. Vytrus Biotech's EBIT is €632.7K making its interest coverage ratio 5.5. It has cash and short-term investments of €2.2M.

주요 정보

29.8%

부채 비율

€2.03m

부채

이자 보상 비율5.5x
현금€2.22m
주식€6.81m
총 부채€3.84m
총 자산€10.64m

최근 재무 상태 업데이트

업데이트 없음

Recent updates

재무 상태 분석

단기부채: V5P's short term assets (€3.5M) exceed its short term liabilities (€1.1M).

장기 부채: V5P's short term assets (€3.5M) exceed its long term liabilities (€2.8M).


부채 대 자본 내역 및 분석

부채 수준: V5P has more cash than its total debt.

부채 감소: V5P's debt to equity ratio has reduced from 44.8% to 29.8% over the past 5 years.

부채 범위: V5P's debt is well covered by operating cash flow (68.9%).

이자 보장: V5P's interest payments on its debt are well covered by EBIT (5.5x coverage).


대차 대조표


건강한 기업 발견하기